New drug cocktail offers hope for kids with relapsed neuroblastoma
NCT ID NCT07318831
First seen Jan 10, 2026 · Last updated Jun 10, 2026 · Updated 16 times
Summary
This study tests a combination of four drugs (chidamide, dinutuximab beta, irinotecan, and temozolomide) in 27 children whose neuroblastoma has come back or not responded to standard treatment. The goal is to see how well the drugs shrink or control the cancer, while closely watching for side effects. This is a phase II trial, meaning it's an early but important step toward finding better options for these young patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA (NB) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianjin Medical University Cancer Institute & Hospital
RECRUITINGTianjin, Tianjin Municipality, 300060, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.